Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Short-term Investments (2020 - 2023)

IceCure Medical (ICCM) has disclosed Short-term Investments for 3 consecutive years, with $529000.0 as the latest value for Q4 2023.

  • Quarterly Short-term Investments rose 78.72% to $529000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $529000.0 through Dec 2023, up 78.72% year-over-year, with the annual reading at $529000.0 for FY2023, 78.72% up from the prior year.
  • Short-term Investments for Q4 2023 was $529000.0 at IceCure Medical, up from $296000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $4.7 million in Q4 2020, with the low at $296000.0 in Q4 2022.
  • Average Short-term Investments over 3 years is $1.8 million, with a median of $529000.0 recorded in 2023.
  • Peak annual rise in Short-term Investments hit 78.72% in 2023, while the deepest fall reached 78.72% in 2023.
  • Over 3 years, Short-term Investments stood at $4.7 million in 2020, then plummeted by 93.66% to $296000.0 in 2022, then skyrocketed by 78.72% to $529000.0 in 2023.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $529000.0, $296000.0, and $4.7 million for Q4 2023, Q4 2022, and Q4 2020 respectively.